1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cyclosporine as Therapy for Traumatic Brain Injury
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Effect of Cyclosporine on Cytokine Production in Elective Coronary Artery Bypass Grafting : A Sub-Analysis of the CiPRICS (Cyclosporine to Protect Renal Function in Cardiac Surgery) Study
(
- Contribution to journal › Article
- 2021
-
Mark
Evaluation of Diffusion Tensor Imaging and Fluid Based Biomarkers in a Large Animal Trial of Cyclosporine in Focal Traumatic Brain Injury
(
- Contribution to journal › Article
- 2019
-
Mark
Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International Immunocancer Registry (ICIR)
(
- Contribution to journal › Article
- 2018
-
Mark
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients
(
- Contribution to journal › Article
-
Mark
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome
(
- Contribution to journal › Article
- 2017
-
Mark
Cerebral Mitochondrial Dysfunction and the Development of Targeted Therapeutics
2017)(
- Thesis › Doctoral thesis (compilation)
- 2016
-
Mark
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial
(
- Contribution to journal › Article
-
Mark
HESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation
(
- Contribution to journal › Article
- 2013
-
Mark
Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study
(
- Contribution to journal › Article